塩野義製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/11/09 | 6,660 | 6,666 | 6,604 | 6,648 | -38 | -0.6% | 1,074,200 |
2022/11/08 | 6,657 | 6,720 | 6,643 | 6,686 | +86 | +1.3% | 1,319,000 |
2022/11/07 | 6,550 | 6,605 | 6,510 | 6,600 | +74 | +1.1% | 1,204,200 |
2022/11/04 | 6,562 | 6,601 | 6,517 | 6,526 | -169 | -2.5% | 1,925,000 |
2022/11/02 | 6,770 | 6,770 | 6,657 | 6,695 | +5 | +0.1% | 1,827,300 |
2022/11/01 | 6,860 | 6,870 | 6,670 | 6,690 | -200 | -2.9% | 2,270,800 |
2022/10/31 | 6,875 | 6,890 | 6,826 | 6,890 | +66 | +1% | 977,500 |
2022/10/28 | 6,800 | 6,886 | 6,771 | 6,824 | -59 | -0.9% | 1,804,500 |
2022/10/27 | 6,928 | 6,928 | 6,852 | 6,883 | -34 | -0.5% | 1,058,200 |
2022/10/26 | 6,764 | 6,957 | 6,756 | 6,917 | +189 | +2.8% | 1,523,100 |
2022/10/25 | 6,815 | 6,819 | 6,727 | 6,728 | +13 | +0.2% | 1,272,700 |
2022/10/24 | 6,777 | 6,796 | 6,707 | 6,715 | +13 | +0.2% | 976,100 |
2022/10/21 | 6,787 | 6,814 | 6,682 | 6,702 | -146 | -2.1% | 1,907,900 |
2022/10/20 | 6,848 | 6,896 | 6,812 | 6,848 | -97 | -1.4% | 1,071,400 |
2022/10/19 | 6,976 | 6,995 | 6,931 | 6,945 | -15 | -0.2% | 780,600 |
2022/10/18 | 6,917 | 6,978 | 6,911 | 6,960 | +128 | +1.9% | 1,199,700 |
2022/10/17 | 6,926 | 6,926 | 6,808 | 6,832 | -144 | -2.1% | 1,160,200 |
2022/10/14 | 6,850 | 6,987 | 6,822 | 6,976 | +199 | +2.9% | 1,717,000 |
2022/10/13 | 6,918 | 6,924 | 6,771 | 6,777 | -159 | -2.3% | 1,243,900 |
2022/10/12 | 6,923 | 6,987 | 6,914 | 6,936 | -19 | -0.3% | 877,700 |
2022/10/11 | 7,010 | 7,014 | 6,918 | 6,955 | -91 | -1.3% | 1,053,000 |
2022/10/07 | 6,975 | 7,065 | 6,953 | 7,046 | +17 | +0.2% | 1,175,700 |
2022/10/06 | 7,032 | 7,100 | 7,009 | 7,029 | -36 | -0.5% | 1,636,800 |
2022/10/05 | 7,012 | 7,099 | 7,009 | 7,065 | +30 | +0.4% | 1,913,900 |
2022/10/04 | 7,001 | 7,042 | 6,964 | 7,035 | +74 | +1.1% | 1,870,900 |
2022/10/03 | 7,000 | 7,032 | 6,888 | 6,961 | -28 | -0.4% | 1,925,200 |
2022/09/30 | 7,049 | 7,078 | 6,981 | 6,989 | -79 | -1.1% | 3,081,100 |
2022/09/29 | 6,841 | 7,082 | 6,816 | 7,068 | +343 | +5.1% | 5,096,000 |
2022/09/28 | 6,590 | 6,840 | 6,404 | 6,725 | +72 | +1.1% | 5,822,700 |
2022/09/27 | 6,761 | 6,772 | 6,652 | 6,653 | -116 | -1.7% | 1,429,700 |
2022/09/26 | 6,752 | 6,847 | 6,732 | 6,769 | -81 | -1.2% | 1,317,100 |
2022/09/22 | 6,800 | 6,874 | 6,740 | 6,850 | -8 | -0.1% | 1,443,100 |
2022/09/21 | 6,945 | 6,945 | 6,852 | 6,858 | -112 | -1.6% | 1,373,000 |
2022/09/20 | 7,050 | 7,055 | 6,909 | 6,970 | -46 | -0.7% | 1,554,200 |
2022/09/16 | 7,009 | 7,060 | 6,985 | 7,016 | +6 | +0.1% | 1,747,500 |
2022/09/15 | 6,993 | 7,035 | 6,977 | 7,010 | +17 | +0.2% | 928,000 |
2022/09/14 | 7,005 | 7,029 | 6,963 | 6,993 | -148 | -2.1% | 1,644,700 |
2022/09/13 | 7,080 | 7,146 | 7,076 | 7,141 | +91 | +1.3% | 1,200,200 |
2022/09/12 | 7,030 | 7,057 | 7,010 | 7,050 | +20 | +0.3% | 1,074,400 |
2022/09/09 | 6,989 | 7,087 | 6,975 | 7,030 | +190 | +2.8% | 3,045,500 |
2022/09/08 | 6,742 | 6,841 | 6,729 | 6,840 | +159 | +2.4% | 1,411,700 |
2022/09/07 | 6,796 | 6,824 | 6,644 | 6,681 | -142 | -2.1% | 1,559,200 |
2022/09/06 | 6,807 | 6,906 | 6,800 | 6,823 | +55 | +0.8% | 969,200 |
2022/09/05 | 6,742 | 6,810 | 6,735 | 6,768 | +22 | +0.3% | 1,078,600 |
2022/09/02 | 6,735 | 6,748 | 6,687 | 6,746 | +56 | +0.8% | 1,086,600 |
2022/09/01 | 6,758 | 6,771 | 6,675 | 6,690 | -114 | -1.7% | 1,410,600 |
2022/08/31 | 6,797 | 6,816 | 6,773 | 6,804 | -46 | -0.7% | 1,174,500 |
2022/08/30 | 6,780 | 6,864 | 6,775 | 6,850 | +97 | +1.4% | 915,500 |
2022/08/29 | 6,838 | 6,845 | 6,737 | 6,753 | -192 | -2.8% | 1,624,800 |
2022/08/26 | 6,880 | 6,959 | 6,873 | 6,945 | +65 | +0.9% | 760,100 |
501~
550
件表示中 / 3585件
類似銘柄と比較する
現在ご覧いただいている「塩野義」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
塩野義 | 210,200円 | +5.7% | +3.9% | 2.73% | 10.45倍 | 1.38倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
大塚HD | 899,000円 | +14.4% | +120.8% | 1.33% | 20.18倍 | 1.85倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 156,900円 | +12.2% | +180.3% | 4.72% | 56.17倍 | 1.84倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
エーザイ | 468,200円 | +1.7% | -2.9% | 3.42% | 30.71倍 | 1.61倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
協和キリン | 252,700円 | +11.3% | -5.4% | 2.30% | 19.45倍 | 1.53倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
市場注目の銘柄
チャート関連のコラム